NO854333L - Isolering av gener fra gjaerarter av slekten pichia. - Google Patents
Isolering av gener fra gjaerarter av slekten pichia.Info
- Publication number
- NO854333L NO854333L NO854333A NO854333A NO854333L NO 854333 L NO854333 L NO 854333L NO 854333 A NO854333 A NO 854333A NO 854333 A NO854333 A NO 854333A NO 854333 L NO854333 L NO 854333L
- Authority
- NO
- Norway
- Prior art keywords
- dna
- pichia
- plasmid
- gene
- fragment
- Prior art date
Links
- 241000235648 Pichia Species 0.000 title claims description 86
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 65
- 108090000623 proteins and genes Proteins 0.000 title claims description 49
- 238000002955 isolation Methods 0.000 title description 9
- 108020004414 DNA Proteins 0.000 claims description 92
- 239000013612 plasmid Substances 0.000 claims description 78
- 239000012634 fragment Substances 0.000 claims description 69
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 63
- 210000004027 cell Anatomy 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 41
- 101150069554 HIS4 gene Proteins 0.000 claims description 34
- 230000001105 regulatory effect Effects 0.000 claims description 34
- 241000588724 Escherichia coli Species 0.000 claims description 32
- 229920001184 polypeptide Polymers 0.000 claims description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 31
- 230000009466 transformation Effects 0.000 claims description 30
- 238000004519 manufacturing process Methods 0.000 claims description 29
- 239000002609 medium Substances 0.000 claims description 25
- 108020004511 Recombinant DNA Proteins 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 230000001131 transforming effect Effects 0.000 claims description 18
- 230000002950 deficient Effects 0.000 claims description 14
- 239000001963 growth medium Substances 0.000 claims description 13
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 13
- 235000015097 nutrients Nutrition 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 239000013611 chromosomal DNA Substances 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 108091008146 restriction endonucleases Proteins 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 8
- 230000010076 replication Effects 0.000 claims description 8
- RKNHJBVBFHDXGR-KEOHHSTQSA-N 1-(5-phospho-beta-D-ribosyl)-ATP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CN([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)C2=N)=C2N=C1 RKNHJBVBFHDXGR-KEOHHSTQSA-N 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 7
- 239000013605 shuttle vector Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 claims description 5
- 108091026890 Coding region Proteins 0.000 claims description 4
- 108700026244 Open Reading Frames Proteins 0.000 claims description 4
- 241000235070 Saccharomyces Species 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 210000004748 cultured cell Anatomy 0.000 claims description 2
- 239000006151 minimal media Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 1
- 241000235058 Komagataella pastoris Species 0.000 description 32
- 229920001817 Agar Polymers 0.000 description 17
- 239000008272 agar Substances 0.000 description 17
- 239000013598 vector Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 239000000600 sorbitol Substances 0.000 description 14
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 230000008929 regeneration Effects 0.000 description 10
- 238000011069 regeneration method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000011534 incubation Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 239000007984 Tris EDTA buffer Substances 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 4
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 239000007222 ypd medium Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101150009006 HIS3 gene Proteins 0.000 description 2
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007320 rich medium Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 101150005709 ARG4 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101100008030 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CUE1 gene Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 101150085823 hsdR gene Proteins 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/666,578 US4885242A (en) | 1984-10-30 | 1984-10-30 | Genes from pichia histidine pathway and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO854333L true NO854333L (no) | 1986-05-02 |
Family
ID=24674601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO854333A NO854333L (no) | 1984-10-30 | 1985-10-30 | Isolering av gener fra gjaerarter av slekten pichia. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4885242A (de) |
EP (1) | EP0188677A3 (de) |
JP (3) | JP2617443B2 (de) |
AU (1) | AU571748B2 (de) |
DK (1) | DK496285A (de) |
ES (1) | ES8609477A1 (de) |
FI (1) | FI854144L (de) |
GR (1) | GR852608B (de) |
IL (1) | IL76764A0 (de) |
NO (1) | NO854333L (de) |
PT (1) | PT81401B (de) |
ZA (1) | ZA858182B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
IL89993A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of the hiv 24kda gag protein in methylotrophic yeasts |
IL90021A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Process for the production of interferon |
IL89992A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of human serum albumin in methylotrophic yeasts |
CA2000101A1 (en) * | 1988-12-22 | 1990-06-22 | Mary E. Digan | Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase gene |
DD297841A5 (de) * | 1989-02-13 | 1992-01-23 | The Salk Institute Biotechnology/Industrial Associates,Us | Herstellung von superoxiddismutase in pichia pastoris hefezellen |
US5268273A (en) * | 1990-12-14 | 1993-12-07 | Phillips Petroleum Company | Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same |
WO1992013951A1 (en) * | 1991-02-04 | 1992-08-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of human serum albumin in methylotrophic yeast cells |
CA2105064A1 (en) * | 1991-04-01 | 1992-10-02 | Martin Anthony Gleeson | Genes which influence pichia proteolytic activity, and uses therefor |
CA2058820C (en) * | 1991-04-25 | 2003-07-15 | Kotikanyad Sreekrishna | Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells |
US5330901A (en) * | 1991-04-26 | 1994-07-19 | Research Corporation Technologies, Inc. | Expression of human serum albumin in Pichia pastoris |
CA2202351A1 (en) * | 1994-10-18 | 1996-04-25 | George Phillip Vlasuk | Nematode-extracted serine protease inhibitors and anticoagulant proteins |
US5866542A (en) * | 1994-10-18 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5866543A (en) * | 1995-06-05 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5872098A (en) * | 1995-06-05 | 1999-02-16 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5863894A (en) * | 1995-06-05 | 1999-01-26 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5945275A (en) * | 1994-10-18 | 1999-08-31 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
EP1772516A1 (de) * | 1994-10-18 | 2007-04-11 | Dendreon Corporation | Pharmazeutische Zusammensetzung zur Behandlung von Thrombose |
MX9605082A (es) | 1996-10-24 | 1998-04-30 | Univ Autonoma De Nuevo Leon | Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano. |
EP0972847A3 (de) * | 1998-04-24 | 2000-02-09 | Hoechst Marion Roussel | Verfahren zur Detektion von Antimycotika |
EP1073768A2 (de) * | 1998-04-24 | 2001-02-07 | Hoechst Marion Roussel | Verfahren zum screening antimykotischer substanzen unter verwendung essentieller gene aus s. cerevisiae |
US6440414B1 (en) * | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
US6261820B1 (en) * | 1999-10-01 | 2001-07-17 | Amgen Inc. | Fibronolytically active polypeptide |
US7033776B2 (en) * | 1999-12-17 | 2006-04-25 | Amgen Inc. | Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
US7449308B2 (en) * | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US7625756B2 (en) | 2000-06-28 | 2009-12-01 | GycoFi, Inc. | Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
US8697394B2 (en) * | 2000-06-28 | 2014-04-15 | Glycofi, Inc. | Production of modified glycoproteins having multiple antennary structures |
US7863020B2 (en) | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
EP2339013B1 (de) | 2000-06-28 | 2014-07-02 | GlycoFi, Inc. | Expression von Klasse-2-Mannosidase und Klasse-III-Mannosidase in niederen eukaryotischen Zellen |
US7009045B2 (en) * | 2000-07-14 | 2006-03-07 | Archer-Daniels-Midland Company | Transformation systems for flavinogenic yeast |
DE60335602D1 (de) * | 2002-12-18 | 2011-02-17 | Roche Diagnostics Gmbh | Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität |
DE60319333D1 (de) * | 2002-12-20 | 2008-04-10 | Roche Diagnostics Gmbh | Hitzelabile Desoxyribonuklease I-Varianten |
US7332299B2 (en) | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
EP1460425A1 (de) * | 2003-03-17 | 2004-09-22 | Boehringer Mannheim Gmbh | Entglykosilierte Enzymen für Konjugaten |
CA2486195C (en) * | 2003-12-05 | 2012-03-06 | Stephan Glaser | Recombinantly expressed carboxypeptidase b and purification thereof |
AU2006291780B2 (en) * | 2005-09-14 | 2011-12-08 | F. Hoffmann-La Roche Ag | Cleavage of precursors of insulins by a variant of trypsin |
DE202008014341U1 (de) | 2008-10-28 | 2009-02-12 | Heßler, Christoph, Dr. | Mobile Fräse zur Kantenbearbeitung |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE54046B1 (en) * | 1981-08-25 | 1989-05-24 | Celltech Ltd | Expression vectors |
US4617274A (en) * | 1981-10-29 | 1986-10-14 | Phillips Petroleum Company | Biochemical conversions by yeast fermentation at high cell densities |
EP0128743A3 (de) * | 1983-06-07 | 1985-12-27 | Genex Corporation | Expression von Fremdgenen in Hefe |
AU578486B2 (en) * | 1984-08-03 | 1988-10-27 | Ronald Norman Belsham | Picture frame clamp |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
-
1984
- 1984-10-30 US US06/666,578 patent/US4885242A/en not_active Expired - Lifetime
-
1985
- 1985-10-16 AU AU48751/85A patent/AU571748B2/en not_active Ceased
- 1985-10-20 IL IL76764A patent/IL76764A0/xx unknown
- 1985-10-23 FI FI854144A patent/FI854144L/fi not_active Application Discontinuation
- 1985-10-24 ZA ZA858182A patent/ZA858182B/xx unknown
- 1985-10-29 ES ES548305A patent/ES8609477A1/es not_active Expired
- 1985-10-29 DK DK496285A patent/DK496285A/da not_active Application Discontinuation
- 1985-10-29 EP EP85113734A patent/EP0188677A3/de not_active Withdrawn
- 1985-10-29 GR GR852608A patent/GR852608B/el unknown
- 1985-10-30 NO NO854333A patent/NO854333L/no unknown
- 1985-10-30 PT PT81401A patent/PT81401B/pt not_active IP Right Cessation
- 1985-10-30 JP JP60243783A patent/JP2617443B2/ja not_active Expired - Lifetime
-
1994
- 1994-09-07 JP JP6213968A patent/JPH07163354A/ja active Pending
-
1996
- 1996-12-09 JP JP8328822A patent/JP2710610B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0188677A3 (de) | 1987-09-30 |
ZA858182B (en) | 1986-06-25 |
PT81401B (pt) | 1987-11-11 |
JPS61108391A (ja) | 1986-05-27 |
FI854144A0 (fi) | 1985-10-23 |
IL76764A0 (en) | 1986-02-28 |
GR852608B (de) | 1986-03-04 |
JP2710610B2 (ja) | 1998-02-10 |
DK496285D0 (da) | 1985-10-29 |
ES8609477A1 (es) | 1986-07-16 |
PT81401A (en) | 1985-11-01 |
JPH09168388A (ja) | 1997-06-30 |
EP0188677A2 (de) | 1986-07-30 |
US4885242A (en) | 1989-12-05 |
ES548305A0 (es) | 1986-07-16 |
FI854144L (fi) | 1986-05-01 |
DK496285A (da) | 1986-05-01 |
JP2617443B2 (ja) | 1997-06-04 |
AU4875185A (en) | 1986-06-12 |
AU571748B2 (en) | 1988-04-21 |
JPH07163354A (ja) | 1995-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO854333L (no) | Isolering av gener fra gjaerarter av slekten pichia. | |
EP0226752B1 (de) | Methode zur erhöten Expression von Polypeptiden in Hefe des Gattung Pichia | |
EP0096430B2 (de) | Klonierungssystem für kluyveromyce Spezies | |
NO177269B (no) | Autonome replikasjonssekvenser (PARS) for gjærarter av slekten Pichia og plasmid inneholdende disse | |
Jarvis et al. | Identification of a DNA segment that is necessary and sufficient for α-specific gene control in Saccharomyces cerevisiae: implications for regulation of α-specific and a-specific genes | |
NO864276L (no) | Gen som koder for produksjonen av pichia-argininsuccinatlyase. | |
CA1339099C (en) | Yeast vector | |
US5166329A (en) | DNA encoding the alcohol oxidase 2 gene of yeast of the genus Pichia | |
NO178076B (no) | Fremgangsmåte til å fremstille heterologe proteiner i Pichia pastoris ved bruk av ekspresjonsvektorer inneholdende sekvenser som induseres av metanol | |
NO301285B1 (no) | DNA-sekvens som koder for det regulatoriske område for alkoholoksidase II hos Pichia pastoris | |
DK171879B1 (da) | Fremgangsmåde til transformation af Yarrowia lipolytica og fremgangsmåde til kloning af gener ved komplementering af mutanter i Y.lipolytica | |
US5135868A (en) | Cultures of yeast of the genus Pichia altered by site selective genomic modification | |
WO1988010308A1 (en) | Pheromone-inducible yeast promoter | |
EP0399455B1 (de) | Stabil transformierte Hefezellen und ihre Verwendung zur Herstellung von Albumin | |
Toh-e et al. | Las21 participates in extracellular/cell surface phenomena in Saccharomyces cerevisiae | |
NO891485L (no) | Fremgangsmaate til fremstilling av 22 kd sgh-protein og lineaer genevektor. | |
IE83234B1 (en) | DNA fragment encoding an AOX | |
NO315206B1 (no) | Nye celler inneholdende alkoholoksidase II regulatorisk område |